Clinical Trials Browser

Phase 2 × Leukemia, Myeloid, Acute × pegylated granulocyte colony-stimulating factor, human × Clear all

NCT03045627 2017-02-07

Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute